TP53 and bladder transitional cell carcinoma: These results indicated that the expression of these three key genes may represent a marker of poor prognosis in BLCA, as well as in nonpapillary tumors, the basal squamous subtype, TP53 mutation patients, tumor with high TMB, and the C2 subtype.